{"name":"Vital Therapies, Inc.","slug":"vital-therapies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ELAD treatment","genericName":"ELAD treatment","slug":"elad-treatment","indication":"Acute liver failure (fulminant hepatic failure) as a bridge to transplantation or recovery","status":"phase_3"}]}],"pipeline":[{"name":"ELAD treatment","genericName":"ELAD treatment","slug":"elad-treatment","phase":"phase_3","mechanism":"ELAD is an extracorporeal liver assist device that uses hepatocyte-based bioreactor technology to provide liver support and detoxification functions in patients with acute liver failure.","indications":["Acute liver failure (fulminant hepatic failure) as a bridge to transplantation or recovery"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBTY1YtbmVnS3YwbVFNYWFCd24yV1ZtaXYwVHhVV1cxMGNPSzhjX1NfUWw5d3pLSkRPX1pEMTU0RzVPV2tud0dva000NFNPa1huNmJvRW9UWTVPd2JBeEHSAWNBVV95cUxQcVRTNlFhbmdteWtyUnVqck5hUzA1TUFfTS1PSGs2X0FMejJFVmdod1pwc0ptUm5uWnI3b1VKVHVXdE9peVBrRGZPV0RvUXJMUGhHenVkYzBIc1hoaWVsR0RJZ0k?oc=5","date":"2026-03-24","type":"trial","source":"Bitget","summary":"SamaCare’s Data Advantage Aims to Address Pharma’s Prior Authorization Challenges—See Data Sales Growth as 2027 FHIR Mandate Approaches - Bitget","headline":"SamaCare’s Data Advantage Aims to Address Pharma’s Prior Authorization Challenges—See Data Sales Growth as 2027 FHIR Man","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNNXFOeWdKSzJLRWpsRWFfc3ViVmRrM1VyRHFBb2YyN0hrMXhsaVJ1U0E2NkZUODE1SDVwenJabTRHeHIyZnd1czJGU096T0pVamc2ekNwSjQzU2VoaHRzMFlvMmVLUVlVUUJCTnVvWlZES3BzR2lMZzlPMnJqdTdfbndZQUJOT0w5bzJiN3JB?oc=5","date":"2026-01-07","type":"pipeline","source":"citybiz","summary":"Mediar Therapeutics Raises $76 Million Series B - citybiz","headline":"Mediar Therapeutics Raises $76 Million Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPUU1SRTdTdzgtdW1Ndk9FdVA5X2NvUUlEQmhnNm5fVjBUdjdnTnFtaTRkZGFwTkZKUUo4TFhKMHM2Qm9xQ3B4Umt0Y0lGa1BJekZLeDlrTnpBc05FbzU0eVJWUDF2WTh3MXZkR2NBVjhMY0JOYmJMaGU0TXV4b0JpSGd0VzkwWlduWjQwXzNMY2IxNjVEVTRCVjVCZEJKQVlRSk1pQjZNcFpqREx0Q0dTaEhQb1RkMjFlOTBjeWVHRGp4SUtXaTJXVVo4OUVvMWplUlE4V2xDSEZrS0h3RnhocHB4dk4ya002d0x4OGszVURocWxHR3h5cXRqS21mX2VwRkNwa3ZNbGs?oc=5","date":"2025-12-02","type":"pipeline","source":"businesswire.com","summary":"AOM Infusion Designated a Limited Distribution Network Specialty Pharmacy for YIMMUGO® Immunoglobulin Replacement Therapy - businesswire.com","headline":"AOM Infusion Designated a Limited Distribution Network Specialty Pharmacy for YIMMUGO® Immunoglobulin Replacement Therap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPTFlEMENIbllkTXBfUXppZWpxR2NqbHU3dlhJdkk1UHJQN0UydS1EQ3BlZWRsZFZJWWZpcFJtazdfY0szSlVRRjRGUEtnTUJQUzVKbGkyUzNhTlhtZEl6TUQzYU5tVUp2c0FObTNENGlfaUwyb2dVcUwwR3dRQzQxaVRQWUI0Q2ViSFBTUkZhNEl0Y2R3SHJzRVBoaXJmMlJKY1A1aC1kSGpPUDFGU0dyYlVnUFBDUUtiVDM0cGhrMUxmd0VkbV81R0Uwc1FLZEZuVGtSQ2xVOEVRTU1wNmFzaHB6Nkc5YkFzM0lOaGZn?oc=5","date":"2025-12-01","type":"deal","source":"GOV.UK","summary":"Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses - GOV.UK","headline":"Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and busines","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-18","type":"regulatory","source":"Indian Pharma Post","summary":"Ingenus Pharma launches first FDA-approved generic version of Premarin - Indian Pharma Post","headline":"Ingenus Pharma launches first FDA-approved generic version of Premarin","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBrU0pwZWwzR2QxcXRpUEU0UEhIZzVsUUNWS2pSSWxxY25VQVd6enNmdDVzM091d1l0cmZTZ2dIMmNxWGUyV3d4Tk1feVQ0TndYY3UzYXpxa0lSN0Q2b0dVZ09mcHZHY1dKNnk4LThod3VYWENwVDU4?oc=5","date":"2025-10-31","type":"pipeline","source":"Fierce Biotech","summary":"The 2025 Biotech Graveyard - Fierce Biotech","headline":"The 2025 Biotech Graveyard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNb2VxNkF5dDZZejI1QWVpcld4MjZJWGlYU0h5dUY5cjhmc3NvWE9tUVJ6VFdZUGdXWkI2MUtHcGlIMXdlWnpLRDdYdWpLNW5LRnQwelN4MHFYNXd1NE1YVjZ0bVJnMFBqTEFkTHlvcVlsdDVsTHZfQ2M5N3NwQ19pazJkbU5YdW5FM2lXUU5kWl8wd0l2aUt2d2liV3RSRm8xb1hORg?oc=5","date":"2025-10-27","type":"pipeline","source":"Contract Pharma","summary":"Bora Pharmaceuticals to Scale Supply of Oncology Therapy - Contract Pharma","headline":"Bora Pharmaceuticals to Scale Supply of Oncology Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNWWJWV3hXbFBOWGpqX1QzcFl4RlNSU2o1cHN0VGVMVnlPTDN3dGdWOG82M1ZWaUliNi1kRVlVbVppbWJXdnczY040STZHZ2VrTnA0Und3MVFsd1JwOXpvRkxBUWt0Mm9iZUxBX1RhZXlVQXd1SGxOUmdCZTlmdE1MS1VIUUxEOENnMFVIeVBndw?oc=5","date":"2025-10-24","type":"pipeline","source":"Yahoo Finance","summary":"How direct-to-patient deliveries are shaping pharma - Yahoo Finance","headline":"How direct-to-patient deliveries are shaping pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBKSzVWVk5vc3ZDUTZOTVVGMmVSX1FWNFJ2djJQbncwV012NHpBYWdDUjdIZ01PUy1zU1Q2MHo2MnMzUmlxaFFPUmd0d1BkUEhlSnlEY2JpVGx5dllmSFZHdzRKYTRaNGNRbmgtWHRiV1ZuU05G?oc=5","date":"2025-06-24","type":"pipeline","source":"Market.us","summary":"Enzyme Replacement Therapy Market Size Analysis | CAGR 9.1% - Market.us","headline":"Enzyme Replacement Therapy Market Size Analysis | CAGR 9.1%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQUGN5SzNkLUszX0NNSjE0TkpzRTBYUHNhUTBDSUVEbk5BQm5MMC1ZX2hFZTZfRjBkZW9hYURMaDhDQThPaXZJc09CdlhvQ3ZtZFEtRFMtZE5Va1QzUzQtSmp6TUdSLTR0MTVhMVloeXViYmhvdVlrRzBQVVVBRVdTTzlDUWtsRUsyWVJCVFdWbWxkNjhhYVVjN3JreHB6STNaei1mT1Rn?oc=5","date":"2025-06-09","type":"pipeline","source":"PharmTech.com","summary":"Tjoapack Announces Packaging, Cold Chain Expansions in US and Netherlands - PharmTech.com","headline":"Tjoapack Announces Packaging, Cold Chain Expansions in US and Netherlands","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxNYWE3cGhyb0ZCbmdUQjVuV2RsZW5nS25EYmJqUmE2U1N4YmVqOVo0bkNFdzhoSUU5NUwxS0sxdVM4WkFldmx5T19tdTZ4ZHZyZ0FQNWRXSWRLUHVFZEs2ZDRWNzREcFp4Q0JyQ0RmUTFZbEFGZHpLS1dabUgzd21nS2VLd3h5UU54NHFvdldwa21iWkJWMHBqOUwxYzhBUGpNa1dRVU45eVpJQklseFNrNEx3U1NibEFOREpXcTFzMzJsT3JlUmc1cC1lREYzb29NM3NXam8zemctWWZ0dnI1dnNnYXRPOGRQQWdUYTkydVNzLVJNRmRhb1RxN3JSR2RfRUdWRVBaNkJXdGpIRjNEcS01ZzU5aVFsYzMxNVRmNGlBVmFVd1Q5YXdqMA?oc=5","date":"2019-04-12","type":"pipeline","source":"prnewswire.com","summary":"Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases - prnewswire.com","headline":"Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOVlp6RFRSdmNkMWVfTy1ESWRWQUtXMzlUSnJWU2RoZFFlLXFnanNSTndEMzdmclAybGtPMzFmOWZMamFXejBadjJhNjhCQ1VMMldqV19FaWlhWVpXRkZqd0pSRlRWN1d5WkczUHRVNXkteEpxa0tRWTJlY3prc2NCdkRMOFNxSzlFczNETDVvVVdvblp3MW1KXw?oc=5","date":"2018-09-12","type":"pipeline","source":"BioPharma Dive","summary":"Vital Therapies plunges on liver treatment failure - BioPharma Dive","headline":"Vital Therapies plunges on liver treatment failure","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}